Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1377/hlthaff.2020.01523 http://scihub22266oqcxt.onion/10.1377/hlthaff.2020.01523 33211554!ä!33211554 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Health+Aff+(Millwood) 2021 ; 40 (1): 33-41 Nephropedia Template TP {{tp|p=33211554|t=2021. COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now |pdf=|usr=}}{{33211554}} gab.com Text COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now JO: Health Aff (Millwood) http://www.kidney.de/pget.php?&tw=1&pmid=33211554 #FOAvip Worldwide, leaders are implementing nonpharmaceutical interventions to slow transmission of the novel coronavirus while pursuing vaccines that confer immunity to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. In this article we describe lessons learned from past pandemics and vaccine campaigns about the path to successful vaccine delivery. The historical record suggests that to have a widely immunized population, leaders must invest in evidence-based vaccine delivery strategies that generate demand, allocate and distribute vaccines, and verify coverage. To generate demand, there must be an understanding of the roots of vaccine hesitancy, involvement of trusted sources of authority in advocacy for vaccination, and commitment to longitudinal engagement with communities. To allocate vaccines, qualified organizations and expert coalitions must be allowed to determine evidence-based vaccination approaches and generate the political will to ensure the cooperation of local and national governments. To distribute vaccines, the people and organizations with expertise in manufacturing, supply chains, and last-mile distribution must be positioned to direct efforts. To verify vaccine coverage, vaccination tracking systems that are portable, interoperable, and secure must be identified. Lessons of past pandemics suggest that nations should invest in evidence-informed strategies to ensure that coronavirus disease 2019 (COVID-19) vaccines protect individuals, suppress transmission, and minimize disruption to health services and livelihoods. Twit Text FOAVip COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now ????Health Aff (Millwood) http://www.kidney.de/pget.php?&tw=1&pmid=33211554 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33211554 #FOAvip English Wikipedia <ref>{{Cite pmid|33211554}}</ref> COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now #MMPMID33211554 Weintraub RL; Subramanian L; Karlage A; Ahmad I; Rosenberg J Health Aff (Millwood) 2021[Jan]; 40 (1): 33-41 PMID33211554show ga Worldwide, leaders are implementing nonpharmaceutical interventions to slow transmission of the novel coronavirus while pursuing vaccines that confer immunity to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. In this article we describe lessons learned from past pandemics and vaccine campaigns about the path to successful vaccine delivery. The historical record suggests that to have a widely immunized population, leaders must invest in evidence-based vaccine delivery strategies that generate demand, allocate and distribute vaccines, and verify coverage. To generate demand, there must be an understanding of the roots of vaccine hesitancy, involvement of trusted sources of authority in advocacy for vaccination, and commitment to longitudinal engagement with communities. To allocate vaccines, qualified organizations and expert coalitions must be allowed to determine evidence-based vaccination approaches and generate the political will to ensure the cooperation of local and national governments. To distribute vaccines, the people and organizations with expertise in manufacturing, supply chains, and last-mile distribution must be positioned to direct efforts. To verify vaccine coverage, vaccination tracking systems that are portable, interoperable, and secure must be identified. Lessons of past pandemics suggest that nations should invest in evidence-informed strategies to ensure that coronavirus disease 2019 (COVID-19) vaccines protect individuals, suppress transmission, and minimize disruption to health services and livelihoods. |COVID-19 Vaccines/*administration & dosage[MESH] |COVID-19/*prevention & control[MESH] |Delivery of Health Care/*organization & administration[MESH] |Humans[MESH] |Immunization Programs/*organization & administration[MESH]COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery S(epmc).pdf DeepDyve Pubget Overpricing